Your browser doesn't support javascript.
loading
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor.
Wolstein, Orit; Boyd, Maureen; Millington, Michelle; Impey, Helen; Boyer, Joshua; Howe, Annett; Delebecque, Frederic; Cornetta, Kenneth; Rothe, Michael; Baum, Christopher; Nicolson, Tamara; Koldej, Rachel; Zhang, Jane; Keech, Naomi; Camba Colón, Joanna; Breton, Louis; Bartlett, Jeffrey; An, Dong Sung; Chen, Irvin Sy; Burke, Bryan; Symonds, Geoff P.
Afiliação
  • Wolstein O; Calimmune Pty Ltd , Darlinghurst, New South Wales, Australia.
  • Boyd M; Calimmune Pty Ltd , Darlinghurst, New South Wales, Australia.
  • Millington M; Calimmune Pty Ltd , Darlinghurst, New South Wales, Australia.
  • Impey H; Calimmune Pty Ltd , Darlinghurst, New South Wales, Australia.
  • Boyer J; UCLA AIDS Institute , Los Angeles, California, USA ; Division of Hematology-Oncology, David Geffen School of Medicine at UCLA , Los Angeles, California, USA.
  • Howe A; Calimmune Pty Ltd , Darlinghurst, New South Wales, Australia.
  • Delebecque F; Calimmune Pty Ltd , Darlinghurst, New South Wales, Australia.
  • Cornetta K; Department of Medical and Molecular Genetics, Indiana University School of Medicine , Indianapolis, Indiana, USA.
  • Rothe M; Institute of Experimental Hematology, Hannover Medical School , Hannover, Germany.
  • Baum C; Institute of Experimental Hematology, Hannover Medical School , Hannover, Germany.
  • Nicolson T; Calimmune Pty Ltd , Darlinghurst, New South Wales, Australia.
  • Koldej R; Calimmune Pty Ltd , Darlinghurst, New South Wales, Australia.
  • Zhang J; Calimmune Inc. , Los Angeles, California, USA.
  • Keech N; Calimmune Inc. , Los Angeles, California, USA.
  • Camba Colón J; Calimmune Inc. , Los Angeles, California, USA.
  • Breton L; Calimmune Inc. , Los Angeles, California, USA.
  • Bartlett J; Calimmune Inc. , Los Angeles, California, USA.
  • An DS; UCLA AIDS Institute , Los Angeles, California, USA ; Division of Hematology-Oncology, David Geffen School of Medicine at UCLA , Los Angeles, California, USA ; UCLA School of Nursing , Los Angeles, California, USA.
  • Chen IS; UCLA AIDS Institute , Los Angeles, California, USA ; Department of Microbiology, Immunology, and Molecular Genetics, University of California , Los Angeles, California, USA ; Department of Medicine, University of California , Los Angeles, California, USA.
  • Burke B; Calimmune Inc. , Los Angeles, California, USA.
  • Symonds GP; Calimmune Pty Ltd , Darlinghurst, New South Wales, Australia.
Mol Ther Methods Clin Dev ; 1: 11, 2014.
Article em En | MEDLINE | ID: mdl-26015947
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article